Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse.
Journal Information
Full Title: Aliment Pharmacol Ther
Abbreviation: Aliment Pharmacol Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of personal interests : Dr Andrew Robinson has acted as a consultant to Abbott, Chiesi, Dr Falk Pharma, Ferring Pharmaceuticals, Shire Pharmaceuticals and Warner Chilcott. Dr Matthew Hankins acted as a consultant to Sciensus Ltd in conducting this study. Gwen Wiseman is an employee of Warner Chilcott UK Ltd. Matthew Jones is an employee of Sciensus Ltd. Declaration of funding interests : This study was funded in full by Warner Chilcott UK Ltd. Editorial support was provided by Acumen Healthcare Communications Ltd, funded by Warner Chilcott."
"Declaration of funding interests: This study was funded in full by Warner Chilcott UK Ltd. Editorial support was provided by Acumen Healthcare Communications Ltd, funded by Warner Chilcott."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025